IMGN Stock Quick Win Stock Forecast by the Algorithm: IMGN a Bullish Winner

Quick Win By The Algorithm

On April 3rd, 2017, the I Know First algorithm issued a bullish 3-month forecast for ImmunoGen (NASDAQ: IMGN). IMGN had a signal of 636.0 and a predictability of 0.49. As a result, in accordance with the forecast, the company’s stock delivered a return of 83.72% over the 3-month period, completing a quick win by the algorithm.


ImmunoGen is an American biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. Founded in 1981, IMGN is equipped with experts in the healthcare space and those with in-depth experience in other key areas of business. With a pipeline of over 20 compounds, one of which is currently being offered on the market, ImmunoGen has established itself unquestionably as a recognized leader in the field. The potential for this company is immense, in line with the predictions put forth by the I Know First algorithm.


Since the algorithm generated this forecast, IMGN’s common shares have risen noticeably from approximately $3.64 to $6.81, or 83.72% increase. IMGN had been up on the monthly timeframe, sideways on the weekly timeframe, and down on the daily timeframe. Over the past few months, while market participants were frowning over the weak top-line and bottom-line figures and reflecting this sentiment in IMGN’s share price, the market overlooked the encouraging positive clinical trial data on its multi-drug pipeline and its cash position, both included in its investor presentation. Following the additional Q1 2017 top-line and bottom-line expectations beat, market participants regained interest in IMGN for a long position. The trend is expected to continue.

Current I Know First subscribers received this bullish IMGN forecast on April 3rd, 2017. 

Before making any trading decisions, consult the latest forecast as the algorithm updates predictions daily. You can use the algorithm for intra-day trading. The predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.